---
figid: PMC3431627__zbc0351219450007
figlink: /pmc/articles/PMC3431627/figure/F7/
number: F7
caption: Potential mechanisms of acquired-resistance to vemurafenib. Two major mechanisms,
  compensatory mechanism and genetic mutation, potentially contribute to acquired-resistance
  to vemurafenib in B-RAF V600E melanoma. Compensatory mechanism of acquired-resistance
  primarily involves Ras activation in response to upstream RTKs signaling such as
  FGFR3, PDGFRβ, or IGF-1R. Ras activation induces resistance to B-RAF inhibition
  primarily by reactivation of RAF/MEK/ERK pathway, and activation of alternate signaling
  pathways such as PI3K/Akt in certain context (, ). In addition, COT activation was
  also reported as a potential compensatory mechanism to compromise B-RAF inhibition
  (). A second major resistant mechanism is vemurafenib treatment-induced genetic
  mutations that result in reactivation of ERK signaling. The mutations identified
  to date include N-Ras Q61K/R (), MEK C121S (), or K-Ras K117N ().
pmcid: PMC3431627
papertitle: Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF
  Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant
  Melanoma .
reftext: Vipin Yadav, et al. J Biol Chem. 2012 Aug 10;287(33):28087-28098.
pmc_ranked_result_index: '17874'
pathway_score: 0.9013418
filename: zbc0351219450007.jpg
figtitle: Mechanisms of acquired-resistance to vemurafenib
year: '2012'
organisms: Homo sapiens
ndex: ab8b9755-deaa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3431627__zbc0351219450007.html
  '@type': Dataset
  description: Potential mechanisms of acquired-resistance to vemurafenib. Two major
    mechanisms, compensatory mechanism and genetic mutation, potentially contribute
    to acquired-resistance to vemurafenib in B-RAF V600E melanoma. Compensatory mechanism
    of acquired-resistance primarily involves Ras activation in response to upstream
    RTKs signaling such as FGFR3, PDGFRβ, or IGF-1R. Ras activation induces resistance
    to B-RAF inhibition primarily by reactivation of RAF/MEK/ERK pathway, and activation
    of alternate signaling pathways such as PI3K/Akt in certain context (, ). In addition,
    COT activation was also reported as a potential compensatory mechanism to compromise
    B-RAF inhibition (). A second major resistant mechanism is vemurafenib treatment-induced
    genetic mutations that result in reactivation of ERK signaling. The mutations
    identified to date include N-Ras Q61K/R (), MEK C121S (), or K-Ras K117N ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR3
  - TRAF1
  - AKT2
  - MAP2K1
  - PIK3R3
  - TRAF5
  - KRAS
  - AKT3
  - PIK3CG
  - TRAF4
  - NRAS
  - HRAS
  - CROT
  - MAPK3
  - IGF1R
  - AKT1
  - TRAF7
  - RAF1
  - BRAF
  - PIK3R5
  - PDGFRB
  - TRAF3
  - TRAF6
  - PIK3CB
  - TRAF2
  - PIK3R6
  - MAPK1
  - PIK3CD
  - PIK3CA
  - MAP2K2
  - PIK3R4
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: (FGFR3,PDGFRB,
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF1
  entrez: '7185'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: KRas
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF4
  entrez: '9618'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: COT,CRaf
  symbol: COT
  source: hgnc_alias_symbol
  hgnc_symbol: CROT
  entrez: '54677'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IGF-1R)
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF7
  entrez: '84231'
- word: COT,CRaf
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: BRaf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: NRas
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: (FGFR3,PDGFRB,
  symbol: PDGFRB
  source: hgnc_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3431627__F7
redirect_from: /figures/PMC3431627__F7
figtype: Figure
---
